Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of -346.64% is 18% above its 5-year average of -423.25%, near the high end of its 5-year range (-733.93%–-206.58%).
7.32% above its 12-month average of -374.01%.
Reported quarterly EBITDA margin; no daily interpolation. Q4 FY2025 (2025-12-31): -662.04%.
EBITDA MARGIN
-346.64%
EBITDA MARGIN AVG TTM
-374.01%
EBITDA MARGIN AVG 3Y
-430.80%
EBITDA MARGIN AVG 5Y
-423.25%
EBITDA MARGIN AVG 10Y
-410.75%
EBITDA MARGIN AVG 15Y
-369.95%
EBITDA MARGIN AVG 20Y
-310.23%
CURRENT VS TTM AVG
+7.32%
CURRENT VS 3Y AVG
+19.54%
CURRENT VS 5Y AVG
+18.10%
CURRENT VS 10Y AVG
+15.61%
CURRENT VS 15Y AVG
+6.30%
CURRENT VS 20Y AVG
-11.74%
Curis, Inc.
Market Cap
$1.47M
EBITDA Margin
-346.64%
TTM Avg
-374.01%
3Y Avg
-430.80%
5Y Avg
-423.25%
Market Cap
$1.46M
EBITDA Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.45M
EBITDA Margin
-75.46%
TTM Avg
-92.89%
3Y Avg
-421.55%
5Y Avg
-389.33%
Market Cap
$1.45M
EBITDA Margin
-1231.39%
TTM Avg
-651.84%
3Y Avg
-512.06%
5Y Avg
-24032.93%
Market Cap
$1.43M
EBITDA Margin
-22.87%
TTM Avg
-29.13%
3Y Avg
-70.31%
5Y Avg
-127.65%
Market Cap
$1.17M
EBITDA Margin
-17.60%
TTM Avg
-16.25%
3Y Avg
-23.94%
5Y Avg
-32.10%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Curis, Inc. (CRIS) | $1.47M | -346.64% | -374.01% | -430.80% | -423.25% |
| Lakewood-Amedex Biotherapeutics, Inc. (LABT)vs › | $1.46M | N/A | N/A | N/A | N/A |
| INVO Fertility, Inc. (IVF)vs › | $1.45M | -75.46% | -92.89% | -421.55% | -389.33% |
| PMGC Holdings Inc. (ELAB)vs › | $1.45M | -1231.39% | -651.84% | -512.06% | -24032.93% |
| NewcelX Ltd. (NCEL)vs › | $1.43M | N/A | N/A | N/A | N/A |
| NEXGEL, Inc. (NXGL)vs › | $1.43M | -22.87% | -29.13% | -70.31% | -127.65% |
| Artelo Biosciences, Inc. (ARTL)vs › | $1.40M | N/A | N/A | N/A | N/A |
| Genprex, Inc. (GNPX)vs › | $1.31M | N/A | N/A | N/A | N/A |
| IM Cannabis Corp. (IMCC)vs › | $1.17M | -17.60% | -16.25% | -23.94% | -32.10% |
| Jupiter Neurosciences, Inc. (JUNS)vs › | $1.18M | -40873.19% | -40873.19% | -21172.28% | -10780.34% |
Gross Margin
99.3%
EBITDA Margin
-346.6%
Operating Margin
-348.4%
Net Margin
-490.3%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2025-12-31 | -662.04% |
| 2025-09-30 | -216.69% |
| 2025-06-30 | -298.62% |
| 2025-03-31 | -424.29% |
| 2024-12-31 | -268.40% |
| 2024-09-30 | -358.44% |
| 2024-06-30 | -489.00% |
| 2024-03-31 | -594.68% |
| 2023-12-31 | -450.11% |
| 2023-09-30 | -434.35% |
| 2023-06-30 | -549.57% |
| 2023-03-31 | -503.40% |
| 2022-12-31 | -350.81% |
| 2022-09-30 | -444.07% |
| 2022-06-30 | -627.54% |
| 2022-03-31 | -733.93% |
| 2021-12-31 | -392.89% |
| 2021-09-30 | -329.45% |
| 2021-06-30 | -464.09% |
| 2021-03-31 | -400.05% |
| 2020-12-31 | -206.58% |
| 2020-09-30 | -169.91% |
| 2020-06-30 | -228.43% |
| 2020-03-31 | -312.18% |
| 2019-12-31 | -222.27% |
| 2019-09-30 | -185.33% |
| 2019-06-30 | -291.74% |
| 2019-03-31 | -312.56% |
| 2018-12-31 | -185.48% |
| 2018-09-30 | -223.99% |
| 2018-06-30 | -331.38% |
| 2018-03-31 | -399.31% |
| 2017-12-31 | -216.71% |
| 2017-09-30 | -589.53% |
| 2017-06-30 | -633.24% |
| 2017-03-31 | -703.80% |
| 2016-12-31 | -453.47% |
| 2016-09-30 | -1576.92% |
| 2016-06-30 | -632.40% |
| 2016-03-31 | -508.26% |
| 2015-12-31 | -631.19% |
| 2015-09-30 | -234.87% |
| 2015-06-30 | -351.91% |
| 2015-03-31 | -1868.15% |
| 2014-12-31 | -239.38% |
| 2014-09-30 | -267.09% |
| 2014-06-30 | -31.39% |
| 2014-03-31 | -367.13% |
| 2013-12-31 | -291.71% |
| 2013-09-30 | 2.32% |
| 2013-06-30 | -12.45% |
| 2013-03-31 | -496.10% |
| 2012-12-31 | -794.43% |
| 2012-09-30 | -853.29% |
| 2012-06-30 | -55.06% |
| 2012-03-31 | 21.53% |
| 2011-12-31 | 53.91% |
| 2011-09-30 | -3252.18% |
| 2011-06-30 | -1169.58% |
| 2011-03-31 | -3977.36% |
| 2010-12-31 | -5430.10% |
| 2010-09-30 | -49.49% |
| 2010-06-30 | -3797.86% |
| 2010-03-31 | 46.54% |
| 2009-12-31 | -147.37% |
| 2009-09-30 | -510.94% |
| 2009-06-30 | -6417.08% |
| 2009-03-31 | 20.16% |
| 2008-12-31 | -66.58% |
| 2008-09-30 | -5214.92% |
| 2008-06-30 | -63.19% |
| 2008-03-31 | -172.55% |
| 2007-12-31 | 35.40% |
| 2007-09-30 | -294.36% |
| 2007-06-30 | -314.65% |
| 2007-03-31 | -144.27% |
| 2006-12-31 | 15.86% |
| 2006-09-30 | -30.02% |
| 2006-06-30 | -126.03% |
| 2006-03-31 | -139.84% |
| 2005-12-31 | -48.00% |
| 2005-09-30 | 328.95% |
| 2005-06-30 | -306.34% |
| 2005-03-31 | -184.01% |
| 2004-12-31 | -196.89% |
| 2004-09-30 | 384.43% |
| 2004-06-30 | -362.15% |
| 2004-03-31 | -451.85% |
| 2003-12-31 | -609.55% |
| 2003-09-30 | 52.49% |
| 2003-06-30 | -876.80% |
| 2003-03-31 | -891.54% |
| 2002-12-31 | -335.61% |
| 2002-09-30 | -1886.09% |
